Prostate cancer in Victoria in 1993: Patterns of reported management

Medical Journal of Australia

Volumn 172, Issue 6, 2000, Pages 270-274

  Frydenberg, Mark ^a   Giles, Graham G ^b   Mameghan, Hedy ^c   Thursfield, Vicky J ^b   Millar, Jeremy ^d   Wheelahan, John B ^e   Bolton, Damien M ^f   Syme, Rodney R ^f  

^a MONASH UNIVERSITY   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c PETER MACCALLUM CANCER CENTRE   (Australia)

^d ALFRED HOSPITAL   (Australia)

^e Baringa Specialist Centre   (Australia)

^f AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CASE FINDING; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY;

EID: 0034689233     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2000.tb123942.x     Document Type: Article

References (12)

1. McCredie M, Coates M, Churches T, Rogers J. The rising incidence of prostate cancer in Australia: a result of screening? J Epidemiol Biostat 1996; 1: 99-105.
2. Hill DJ, White VM, Giles GG, et al. Changes in the investigation and management of primary operable breast cancer in Victoria. Med J Aust 1994; 160: 110-122.
3. McLeish J, Giles GG, Thursfield V. Investigation, followup and recurrence after resection of colorectal cancer. Aust N Z J Surg 1992; 62: 931-940.
4. Gleason DF, Mellinger GT, The Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58-64.
5. SPSS for Windows [computer program], version 9.01 Chicago. Ill: SPSS Inc. 1999.
6. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual for staging of cancer. 4th edition. American Joint Committee on Cancer. Philadelphia: JB Lippincott, 1992
7. Hédelin G. RELSURV: a program for relative survival. Technical report. Strasbourg, France: Department of Epidemiology and Public Health, Faculty of Medicine, Louis Pasteur University, 1995.
8. National Cancer Control Initiative. Cancer control towards 2000 - the first stage of a nationally coordinated plan for cancer control. Canberra: Commonwealth Department of Health and Family Services, 1998.
9. Mettlin C, Jones GW, Murphy GP. Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA 1993; 43: 83-91.
10. Oesterling JE, Martin SK, Bergstrahl EJ, Lowe FC. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 1993; 269: 57-60.
11. Lee N, Newhouse JH, Olsson CA, et al. Which patients with newly diagnosed prostate cancer need a computed tomography scan of the abdomen and pelvis? An analysis based on 588 patients. Urology 1999; 54: 490-494.
12. Lu-Yao GH, Yao SL Population-based study of long term survival in patients with clinically localised prostate cancer. Lancet 1997; 349: 906-910.